Your browser doesn't support javascript.
loading
Predictors of Patient Engagement in Telehealth-Delivered Tobacco Cessation Treatment during the COVID-19 Pandemic.
Jagielo, Annemarie D; Chieng, Amy; Tran, Cindy; Pirkl, Amy; Cao-Nasalga, Ann; Bragg, Ashley; Mirkin, Rachelle; Prochaska, Judith J.
Afiliación
  • Jagielo AD; PGSP-Stanford PsyD Consortium, Palo Alto University, Palo Alto, CA 94304, USA.
  • Chieng A; Department of Psychiatry & Behavioral Sciences, School of Medicine, Stanford University, Stanford, CA 94305, USA.
  • Tran C; Stanford Prevention Research Center, Department of Medicine, Stanford University, Palo Alto, CA 94304, USA.
  • Pirkl A; Health Education, Engagement and Promotion, Stanford Healthcare, Menlo Park, CA 94025, USA.
  • Cao-Nasalga A; Health Education, Engagement and Promotion, Stanford Healthcare, Menlo Park, CA 94025, USA.
  • Bragg A; Health Education, Engagement and Promotion, Stanford Healthcare, Menlo Park, CA 94025, USA.
  • Mirkin R; Health Education, Engagement and Promotion, Stanford Healthcare, Menlo Park, CA 94025, USA.
  • Prochaska JJ; Health Education, Engagement and Promotion, Stanford Healthcare, Menlo Park, CA 94025, USA.
Int J Environ Res Public Health ; 21(2)2024 Jan 25.
Article en En | MEDLINE | ID: mdl-38397622
ABSTRACT
Smoking causes one in three cancer deaths and may worsen COVID-19 outcomes. Telehealth tobacco cessation treatment is offered as a covered benefit for patients at the Stanford Cancer Center. We examined predictors of engagement during the COVID-19 pandemic. Data were abstracted from the Electronic Health Record between 3/17/20 (start of pandemic shelter-in-place) and 9/20/22, including patient tobacco use, demographics, and engagement in cessation treatment. Importance of quitting tobacco was obtained for a subset (53%). During the first 2.5 years of the pandemic, 2595 patients were identified as recently using tobacco, and 1571 patients were contacted (61%). Of the 1313 patients still using tobacco (40% women, mean age 59, 66% White, 13% Hispanic), 448 (34%) enrolled in treatment. Patient engagement was greater in pandemic year 1 (42%) than in year 2 (28%) and year 3 (19%). Women (41%) engaged more than men (30%). Patients aged 36-45 (39%), 46-55 (43%), 56-65 (37%), and 66-75 (33%) engaged more than patients aged 18-35 (18%) and >75 (21%). Hispanic/Latinx patients (42%) engaged more than non-Hispanic/Latinx patients (33%). Engagement was not statistically significantly related to patient race. Perceived importance of quitting tobacco was significantly lower in pandemic year 1 than year 2 or 3. Nearly one in three cancer patients engaged in telehealth cessation treatment during the COVID-19 pandemic. Engagement was greater earlier in the pandemic, among women, Hispanic/Latinx individuals, and patients aged 36 to 75. Sheltering-in-place, rather than greater perceived risk, may have facilitated patient engagement in tobacco cessation treatment.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cese del Hábito de Fumar / Telemedicina / Cese del Uso de Tabaco / COVID-19 Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Int J Environ Res Public Health Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cese del Hábito de Fumar / Telemedicina / Cese del Uso de Tabaco / COVID-19 Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Int J Environ Res Public Health Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza